This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease or Diabetes Mellitus
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Prospective, randomized, controlled, multicenter, open-label study to compare everolimus-eluting bioresorbable vascular scaffolds to everolimus-eluting stents in patients with diabetes mellitus.

Provided treatments

  • Device: Absorb GT1
  • Device: Promus

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02632292. The sponsor of the trial is University of Luebeck and it is looking for 33 volunteers for the current phase.
Official trial title:
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus